documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
37 rows where docket_id = "FDA-2017-D-0085" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 37
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-0085-0051 | FDA | None FDA-2017-D-0085 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2023-02-14T05:00:00Z | 2023 | 2 | 2023-02-14T05:00:00Z | 2023-02-14T15:00:41Z | 2023-03073 | 0 | 0 | 090000648569352e | |
| FDA-2017-D-0085-0044 | FDA | None FDA-2017-D-0085 | Best Practices for Convening a GRAS Panel; Guidance for Industry; Availability | Notice | Notice of Availability | 2022-12-22T05:00:00Z | 2022 | 12 | 2022-12-22T05:00:00Z | 2022-12-22T14:39:30Z | 2022-27714 | 0 | 0 | 090000648554882e | |
| FDA-2017-D-0085-0045 | FDA | None FDA-2017-D-0085 | Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance | Other | Guidance | 2022-12-21T05:00:00Z | 2022 | 12 | 2022-12-21T05:00:00Z | 2024-11-12T23:49:43Z | 1 | 0 | 0900006485549dab | ||
| FDA-2017-D-0085-0048 | FDA | None FDA-2017-D-0085 | Reference-30-GRAS Notices Search Results Common Use In Food - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance | Supporting & Related Material | Background Material | 2022-12-21T05:00:00Z | 2022 | 12 | 2022-12-21T21:13:51Z | 0 | 0 | 0900006485549f5d | |||
| FDA-2017-D-0085-0046 | FDA | None FDA-2017-D-0085 | Final Guidance - Reference List - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance | Supporting & Related Material | Background Material | 2022-12-21T05:00:00Z | 2022 | 12 | 2022-12-21T21:13:02Z | 0 | 0 | 09000064855494a0 | |||
| FDA-2017-D-0085-0047 | FDA | None FDA-2017-D-0085 | Reference-29-Memorandum-November 4, 2010-Linda Kahl - Substances that Are Generally Recognized as Safe (GRAS); Experience with GRAS Notices - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance | Supporting & Related Material | Background Material | 2022-12-21T05:00:00Z | 2022 | 12 | 2022-12-21T21:13:35Z | 0 | 0 | 09000064855494a1 | |||
| FDA-2017-D-0085-0049 | FDA | None FDA-2017-D-0085 | Reference-31-OECD 2017-Guidance on Grouping of Chemicals- Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance | Supporting & Related Material | Background Material | 2022-12-21T05:00:00Z | 2022 | 12 | 2022-12-21T21:14:18Z | 0 | 0 | 0900006485549f5e | |||
| FDA-2017-D-0085-0050 | FDA | None FDA-2017-D-0085 | Reference-32-Ball 2016-Toward Good Read-Across Practice (GRAP) Guidance- Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance | Supporting & Related Material | Background Material | 2022-12-21T05:00:00Z | 2022 | 12 | 2022-12-21T21:14:43Z | 0 | 0 | 0900006485549f5f | |||
| FDA-2017-D-0085-0042 | FDA | None FDA-2017-D-0085 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Generally Recognized as Safe: Best Practices for Convening a Generally Recognized as Safe Panel | Notice | 30 Day Proposed Information Collection | 2022-10-27T04:00:00Z | 2022 | 10 | 2022-10-27T04:00:00Z | 2022-11-29T04:59:59Z | 2022-12-21T16:18:56Z | 2022-23378 | 0 | 0 | 0900006485462764 |
| FDA-2017-D-0085-0017 | FDA | None FDA-2017-D-0085 | Reference-16-Milch-2009-From-individual-preference-construction-group-decisions-framing-effects-group-processes re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:27Z | 0 | 0 | 0900006482cb21a1 | |||
| FDA-2017-D-0085-0023 | FDA | None FDA-2017-D-0085 | Reference-23-About-FEMA-GRAS-Program re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:58Z | 0 | 0 | 0900006482cb21aa | |||
| FDA-2017-D-0085-0028 | FDA | None FDA-2017-D-0085 | Reference-28-Pew-2013-Draft-COI-Guidance-Consideration-FDA re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:58:20Z | 0 | 0 | 0900006482cb21af | |||
| FDA-2017-D-0085-0003 | FDA | None FDA-2017-D-0085 | GUIDANCE -REFERENCE LIST re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:17Z | 0 | 0 | 0900006482cb1e6f | |||
| FDA-2017-D-0085-0018 | FDA | None FDA-2017-D-0085 | Reference-17-Jonas-2001-Confirmation-bias-sequential-information-search-after-preliminary-decisions re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:32Z | 0 | 0 | 0900006482cb21a2 | |||
| FDA-2017-D-0085-0026 | FDA | None FDA-2017-D-0085 | Reference-26-Guyatt-2010-Vexing-problem-guidelines-conflicts-interest-potential-solution re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:58:11Z | 0 | 0 | 0900006482cb21ad | |||
| FDA-2017-D-0085-0025 | FDA | None FDA-2017-D-0085 | Reference-25-Norris-2011-Conflict-interest-clinical-practice-guideline-development-systematic-review re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:58:07Z | 0 | 0 | 0900006482cb21ac | |||
| FDA-2017-D-0085-0011 | FDA | None FDA-2017-D-0085 | Reference-10-IOM-2009-Conflict-Interest-Medical-Research-Education-Practice re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:58Z | 0 | 0 | 0900006482cb219b | |||
| FDA-2017-D-0085-0016 | FDA | None FDA-2017-D-0085 | Reference-15-Cheng-Chiou-2008-Framing-effects-group-investment-decision-making-role-group-polarization re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:22Z | 0 | 0 | 0900006482cb21a0 | |||
| FDA-2017-D-0085-0019 | FDA | None FDA-2017-D-0085 | Reference-18- Mancuso-2014-Effects-cognitive-biases-distributed-team-decision-making re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:37Z | 0 | 0 | 0900006482cb21a3 | |||
| FDA-2017-D-0085-0024 | FDA | None FDA-2017-D-0085 | Reference-24-Alpert-2004-ACCF-AHA-Codes-Conduct-Human-Studies-Research re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:58:03Z | 0 | 0 | 0900006482cb21ab | |||
| FDA-2017-D-0085-0021 | FDA | None FDA-2017-D-0085 | Reference-20-FDA-2016-Draft-Guidance-Procedures-Evaluating-Appearance-Issues-FDA-Advisory-Committees re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:49Z | 0 | 0 | 0900006482cb21a8 | |||
| FDA-2017-D-0085-0007 | FDA | None FDA-2017-D-0085 | Reference-06-Croskerry-2002-Achieving-quality-clinical-decision-making-cognitive-strategies-detection-bias re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:40Z | 0 | 0 | 0900006482cb1e73 | |||
| FDA-2017-D-0085-0005 | FDA | None FDA-2017-D-0085 | Reference-02-Guidance-Frequently-Asked-Questions-About-GRAS re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:28Z | 0 | 0 | 0900006482cb1e71 | |||
| FDA-2017-D-0085-0012 | FDA | None FDA-2017-D-0085 | Reference-11 NAS-2013-Policy-Committee-Composition-Balance-Conflicts-Interest re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:03Z | 0 | 0 | 0900006482cb219c | |||
| FDA-2017-D-0085-0006 | FDA | None FDA-2017-D-0085 | Reference-03-Report-Congressional-Requestors-Food-Safety-FDA-Should-Strengthen-Oversight-GRAS-Ingredients re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:35Z | 0 | 0 | 0900006482cb1e72 | |||
| FDA-2017-D-0085-0009 | FDA | None FDA-2017-D-0085 | Reference-08-Bazerman-2002-Why-good-accountants-do-bad-audits re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:49Z | 0 | 0 | 0900006482cb1e75 | |||
| FDA-2017-D-0085-0027 | FDA | None FDA-2017-D-0085 | Reference-27-NCCN-2014-NCCN-Disclosure-Policies-Potential-Conflicts-Interest re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:58:16Z | 0 | 0 | 0900006482cb21ae | |||
| FDA-2017-D-0085-0022 | FDA | None FDA-2017-D-0085 | Reference-21-FDA-2014-Guidance-Public-Availability-Advisory-Committee-Members-Financial-Interest-Information-Waivers re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:54Z | 0 | 0 | 0900006482cb21a9 | |||
| FDA-2017-D-0085-0014 | FDA | None FDA-2017-D-0085 | Reference-13-van-Ginkel-van-Knippenberg-2012-Group-leadership-shared-task-representations-decision-making-groups re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:13Z | 0 | 0 | 0900006482cb219e | |||
| FDA-2017-D-0085-0013 | FDA | None FDA-2017-D-0085 | Reference-12-Pagliari-2001-Potential-influence-small-group-processes-guideline-development re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:07Z | 0 | 0 | 0900006482cb219d | |||
| FDA-2017-D-0085-0004 | FDA | None FDA-2017-D-0085 | Reference-01-Guidance-Regulatory-Framework-GRAS-Substances re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:22Z | 0 | 0 | 0900006482cb1e70 | |||
| FDA-2017-D-0085-0010 | FDA | None FDA-2017-D-0085 | Reference-09-Moore-2010-Conflict-of-interest-intrusion-bias re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:53Z | 0 | 0 | 0900006482cb219a | |||
| FDA-2017-D-0085-0008 | FDA | None FDA-2017-D-0085 | Reference-07-Arnott-2006-Cognitive-biases-decision-support-systems-development re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:56:45Z | 0 | 0 | 0900006482cb1e74 | |||
| FDA-2017-D-0085-0015 | FDA | None FDA-2017-D-0085 | Reference-14-Tschan-2009-Explicit-reasoning-confirmation-bias-illusory-transactive-memory re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:18Z | 0 | 0 | 0900006482cb219f | |||
| FDA-2017-D-0085-0020 | FDA | None FDA-2017-D-0085 | Reference- 19-FDA-2008-Guidance-Procedures-Determining-Conflict-Interest-Eligibility-Participation-FDA-Advisory-Committees re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance | Supporting & Related Material | Background Material | 2017-11-27T05:00:00Z | 2017 | 11 | 2017-11-27T21:57:44Z | 0 | 0 | 0900006482cb21a7 | |||
| FDA-2017-D-0085-0001 | FDA | None FDA-2017-D-0085 | Guidance: Best Practices for Convening a Generally Recognized as Safe Panel | Notice | Notice of Availability | 2017-11-16T05:00:00Z | 2017 | 11 | 2017-11-16T05:00:00Z | 2018-05-16T03:59:59Z | 2018-02-08T02:03:44Z | 2017-24845 | 0 | 0 | 0900006482c83776 |
| FDA-2017-D-0085-0002 | FDA | None FDA-2017-D-0085 | Best Practices for Convening a GRAS Panel: Guidance for Industry; Draft Guidance | Other | Guidance | 2017-11-16T05:00:00Z | 2017 | 11 | 2017-11-16T05:00:00Z | 2022-12-21T16:44:12Z | 0 | 0 | 0900006482c84b3d |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;